These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15958577

  • 1. Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
    Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Kanteti PV.
    Cancer Res; 2005 Jun 15; 65(12):5301-9. PubMed ID: 15958577
    [Abstract] [Full Text] [Related]

  • 2. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
    Chu F, Borthakur A, Sun X, Barkinge J, Gudi R, Hawkins S, Prasad KV.
    Apoptosis; 2004 Jan 15; 9(1):83-95. PubMed ID: 14739602
    [Abstract] [Full Text] [Related]

  • 3. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED, Kutuk O, Tezil T, Bodur C, Telci D, Basaga H.
    Breast Cancer Res Treat; 2010 Jan 15; 119(2):271-81. PubMed ID: 19238538
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 5. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
    Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
    Cho HJ, Kim JK, Kim KD, Yoon HK, Cho MY, Park YP, Jeon JH, Lee ES, Byun SS, Lim HM, Song EY, Lim JS, Yoon DY, Lee HG, Choe YK.
    Cancer Lett; 2006 Jun 08; 237(1):56-66. PubMed ID: 16009487
    [Abstract] [Full Text] [Related]

  • 7. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A, Gillissen B, Müller A, Normand G, Hemmati PG, Schuler M, Dörken B, Daniel PT.
    Oncogene; 2004 Jun 03; 23(26):4523-35. PubMed ID: 15064710
    [Abstract] [Full Text] [Related]

  • 8. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 9. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S, Ng CP, Bonavida B.
    Clin Cancer Res; 2002 Mar 07; 8(3):836-45. PubMed ID: 11895917
    [Abstract] [Full Text] [Related]

  • 10. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K, Takemura K, Kihara M, Naito S, Lee E, Shimizu E, Yamauchi A.
    Oncol Rep; 2005 Jun 07; 13(6):1229-34. PubMed ID: 15870947
    [Abstract] [Full Text] [Related]

  • 11. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.
    Cancer Res; 2003 Jun 15; 63(12):3112-20. PubMed ID: 12810637
    [Abstract] [Full Text] [Related]

  • 12. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
    Fernández Y, España L, Mañas S, Fabra A, Sierra A.
    Cell Death Differ; 2000 Apr 15; 7(4):350-9. PubMed ID: 10773819
    [Abstract] [Full Text] [Related]

  • 13. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Kazhdan I, Marciniak RA.
    Cancer Gene Ther; 2004 Oct 15; 11(10):691-8. PubMed ID: 15354201
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS, Lademann U, Jäättelä M.
    Cancer Res; 1999 Oct 01; 59(19):4848-56. PubMed ID: 10519395
    [Abstract] [Full Text] [Related]

  • 15. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 01; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 16. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z, Goulet R, Stanton KJ, Sadaria M, Nakshatri H.
    Anticancer Res; 2005 Jul 01; 25(3c):2367-79. PubMed ID: 16080463
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.
    Arch Virol; 2004 Feb 01; 149(2):289-302. PubMed ID: 14745596
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H, Bouchon A, Stahl H, Krammer PH.
    Cancer Res; 2000 Jun 01; 60(11):3051-7. PubMed ID: 10850456
    [Abstract] [Full Text] [Related]

  • 19. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin.
    Shiu LY, Chang LC, Liang CH, Huang YS, Sheu HM, Kuo KW.
    Food Chem Toxicol; 2007 Nov 01; 45(11):2155-64. PubMed ID: 17619073
    [Abstract] [Full Text] [Related]

  • 20. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
    Huerta S, Heinzerling JH, Anguiano-Hernandez YM, Huerta-Yepez S, Lin J, Chen D, Bonavida B, Livingston EH.
    J Surg Res; 2007 Sep 01; 142(1):184-94. PubMed ID: 17603079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.